The chemical composition of some marketed AMPs. For gramicidin D and teicoplanin, only one of the most ample factors with the clinically used mixtures are revealed. Any likely conflicts of interest, for instance funding from pharmaceutical organizations or personal investments in linked industries, are extensively disclosed in the research publications. https://toddg255cwo9.qodsblog.com/profile